Trained Therapeutix Discovery’s Chief Scientific Officer, Dr. Mulder, Honored with Fellowship at the American Institute for Medical and Biological Engineering (AIMBE)

News

-Recognition highlights pioneering contributions to nanomedicine underpinning the company’s RIDE platform Oss, The Netherlands — April 14, 2026 — Trained Therapeutix Discovery, a biotechnology company founded by the Jean Boulle Group and the Heritage Group, today announced that its Chief Scientific Officer and scientific founder, Willem Mulder, PhD, has been inducted into the College of…

Trained Therapeutix Discovery Appoints Distinguished Industry Leaders to its Board of Directors

News

DALLAS and OSS, The Netherlands, Feb. 09, 2026 (GLOBE NEWSWIRE) — Trained Therapeutix Discovery, a pioneering immunotherapy biotech company revolutionizing the treatment of immune-mediated diseases through its innovative RIDE nanomedicine platform, today announced the appointment of seven distinguished industry leaders to its board of directors. This strategic enhancement positions the company to accelerate the development…

Trained Therapeutix Discovery Demonstrates RIDE-001 Trains Myeloid Cells for Anti-Tumor Immune Response in Preclinical Data Presented at the Society for Immunotherapy of Cancer (SITC) Annual Meeting

News

Trained Therapeutix Discovery Demonstrates RIDE-001 Trains Myeloid Cells for Anti-Tumor Immune Response in Preclinical Data Presented at the Society for Immunotherapy of Cancer (SITC) Annual Meeting -RIDE-001, a first-in-class nanomedicine, effectively trained myeloid progenitor cells to elicit myeloid-driven anticancer innate immune responses, as demonstrated in preclinical studies across multiple species Dallas, TTxD & The Netherlands…

Trained Therapeutix Discovery Appoints Joost Kreijtz, PhD, as Chief Executive Officer of Dutch Subsidiary Trained Therapeutix Discovery (NL)

News

Trained Therapeutix Discovery Appoints Joost Kreijtz, PhD, as Chief Executive Officer of Dutch Subsidiary Trained Therapeutix Discovery (NL) Dallas, TX & The Netherlands — October 17, 2025 — Trained Therapeutix Discovery, Inc., a biotech company training immunity at its origin with nanomedicines, today announced that Joost Kreijtz, PhD, has been appointed Chief Executive Officer of Trained Therapeutix…

Trained Therapeutix Discovery to attend BIO-Europe in Vienna, November 3–5, 2025

News

Trained Therapeutix Discovery is pleased to announce its participation in BIO-Europe, taking place in Vienna from November 3 to 5, 2025. Our management team will be present and welcomes meeting requests to discuss our cutting-edge nanomedicine programs including our lead programs RIDE-001 and RIDE-002. We are open to opportunities for strategic partnerships and investments. BIO-Europe…